Mitsubishi Tanabe Pharma Corporation 4508Short Interest
No institution currently reports a short position of 0.5% or more in Mitsubishi Tanabe Pharma Corporation (4508). The last disclosure was on 2019-10-03 (Morgan Stanley MUFG Securities Co., Ltd., 0.00%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
2 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. How estimates are calculated
Disclosure History Summary
| First disclosure | 2019-10-02 |
|---|---|
| Latest disclosure | 2019-10-03 (Morgan Stanley MUFG Securities Co., Ltd., 0.00%) |
| Reporting institutions | 1 firms (2 reports) |
| Peak estimated short interest | 2.00% (2019-10-02, 1 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
No position of 0.5% or more reported within a year existed in the last 5 years, so no chart is shown. Past disclosures are listed in the tables below.
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2019-10-03 | Morgan Stanley MUFG Securities Co., Ltd. | Position 0 shares | Ratio 0.00% | ▼2.00% | Closed |
Disclosure History 2 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2019-10-03 | Morgan Stanley MUFG Securities Co., Ltd. | Position 0 shares | Ratio 0.00% | ▼2.00% | Closed |
| 2019-10-02 | Morgan Stanley MUFG Securities Co., Ltd. | Position 11,238,204 shares | Ratio 2.00% | ▲2.00% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |